Prostate Cancer - Results from #24320

The role of urine prostate cancer antigen 3 mRNA levels in the diagnosis of prostate cancer among Hong Kong Chinese patients - Abstract January 10, 2013

Prostatic specific antigen and bone scan in the diagnosis and follow-up of prostate cancer. Can diagnostic significance of PSA be increased? - Abstract January 10, 2013

Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study - Abstract January 10, 2013

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: The ProtecT study - Abstract January 9, 2013

Adverse pathological findings in needle biopsy Gleason score 6 prostate cancers with low and intermediate preoperative PSA levels following radical prostatectomy - Abstract January 9, 2013

Effects of post biopsy digital rectal compression on improving prostate cancer staging using magnetic resonance imaging in localized prostate cancer - Abstract January 9, 2013

A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer - Abstract January 9, 2013

Perioperative complications of radical retropubic prostatectomy in patients with locally advanced prostate cancer: A comparison with clinically localized prostate cancer - Abstract January 9, 2013

Key research from the 2013 Genitourinary Cancers Symposium to be featured in February 12 presscast January 8, 2013

Experience in reducing intraoperative blood loss in radical retropubic prostatectomy - Abstract January 8, 2013

The relationship between nutrition and prostate cancer: Is more always better? - Abstract January 8, 2013

Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: Results from a national survey of radiation oncologists and urologists - Abstract January 8, 2013

Androgen Deprivation Therapy and maintenance of intimacy: A randomized controlled pilot study of an educational intervention for patients and their partners - Abstract January 8, 2013

Vitamin D(3) supplementation, low-risk prostate cancer, and health disparities - Abstract January 8, 2013

Does quality of life of prostate cancer patients differ by stage and treatment? - Abstract January 8, 2013

Strategies for optimizing the clinical impact of immunotherapeutic agents such as sipuleucel-T in prostate cancer - Abstract January 8, 2013

Treatment patterns for prostate cancer: Comparison of medicare claims data to medical record review - Abstract January 8, 2013

The role of the elastography in the diagnosis of prostate cancer: A retrospective study on 460 patients - Abstract January 7, 2013

Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysis - Abstract January 7, 2013

How prostate cancer therapies compare by cost and effectiveness January 7, 2013

Page 1217 of 1447